Markers of Thrombin and Platelet Activity in Patients With Atrial Fibrillation
Author(s) -
William M. Feinberg,
Lesly A. Pearce,
Robert G. Hart,
Mary Cushman,
Elaine Cornell,
Gregory Y.H. Lip,
Edwin G. Bovill
Publication year - 1999
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.30.12.2547
Subject(s) - medicine , atrial fibrillation , stroke (engine) , cardiology , aspirin , antithrombotic , platelet activation , heart failure , fibrinogen , risk factor , thrombosis , embolism , platelet , mechanical engineering , engineering
Markers of thrombin generation and platelet activation are often elevated in patients with nonvalvular atrial fibrillation, but it is unclear whether such markers usefully predict stroke. Therefore, we undertook the present study to assess the relationship between prothrombin fragment F1.2 (F1.2), beta-thromboglobulin (BTG), fibrinogen, and the factor V Leiden mutation with stroke in atrial fibrillation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom